QleanAir AB (FRA:9ZJ)

Q4 2024 Qleanair AB Earnings Call Transcript

Feb 7, 2025 / 09:00 AM GMT

Release Date Price: €1.27 (-13.36%)

Transcript

Key Points

Positve

QleanAir AB (FRA:9ZJ) reported a strong cash flow of 17 million SEK, an improvement from 14 million SEK last year.
The company successfully launched new products, which have started shipping and received orders in key European markets.
Japan showed strong growth in air cleaners, with a 55% increase in the quarter and 44% for the year in local currency.
QleanAir AB (FRA:9ZJ) has a solid base of recurring revenues, accounting for 74% of total revenues, providing predictability.
The company is focusing on strategic customer engagement and product development, which has been well-received by sales teams.

Negative

QleanAir AB (FRA:9ZJ) experienced a 16% decline in sales compared to the previous year, primarily due to the absence of the CurEXA contract.
The gross margin decreased from 67% to 66%, and the adjusted operating profit fell from 10 million SEK to 3 million SEK.
Sales in the Americas were significantly impacted by the canceled CurEXA project, dropping from 8 million SEK to 3 million SEK.
The company faced challenges in Japan due to a low point in the renewal base and a 10% worsening of the Japanese yen exchange rate.
QleanAir AB (FRA:9ZJ) had to undertake reductions and reorganizations at the head office in response to weaker sales.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

QAIR.ST - Qleanair AB
Q4 2024 Qleanair AB Earnings Call
Feb 07, 2025 / 09:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to the Clean Air Investor presentation for Q4 2024. My name is Sebastian Lindstrom. I'm the CEO of Clean Air, and joining me in today's call is Henry Kress Mike, our CFO of Clean Air. As said, Henrik and I will go through the presentation and then open up for Q&A at the end.

Starting off with the numbers for Q4, we closed another challenging quarter. The absence of the CurEXA contract and the low point of Japanese renewals to finance companies affected both top and bottom line. Positive in the quarter was that we started to ship the first of the newly launched products and that our cash flow improved both over last year and in a significant way over the previous quarter. We delivered 104 million in sales, which was 16% behind last

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.